Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients. [electronic resource]
Producer: 20001205Description: 991-1000 p. digitalISSN:- 1019-6439
- Aged
- Aneuploidy
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Area Under Curve
- Bone Marrow Diseases -- chemically induced
- Breast Neoplasms -- chemistry
- Carcinoma -- chemistry
- Drug Administration Schedule
- Drug Interactions
- Female
- Follow-Up Studies
- Headache -- chemically induced
- Humans
- Hypercholesterolemia -- chemically induced
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Ki-67 Antigen -- analysis
- Mastectomy
- Middle Aged
- Neoplasm Proteins -- analysis
- Receptors, Retinoic Acid -- analysis
- Receptors, Steroid -- analysis
- Recombinant Proteins
- Safety
- Tamoxifen -- administration & dosage
- Transforming Growth Factor beta -- analysis
- Transforming Growth Factor beta1
- Treatment Outcome
- Tretinoin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.